Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2026 Sep 21;17:1966715. doi: 10.3389/fphar.2026.1966715

Correction: Indobufen-based dual antiplatelet therapy in patients undergoing PCI: a systematic review and meta-analysis

Yiheng Liu 1,2,†, Bin Liu 1,†, Weiran Dai 1,*
PMCID: PMC13635664  PMID: 42835357

Authors Yiheng Liu and Bin Liu were erroneously omitted as equal contributing authors.

The original version of this article has been updated.

Footnotes

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES